Back

Anticoagulant effect and pharmacodynamics of argatroban in critically ill cardiac surgical patients with suspected heparin-induced thrombocytopenia

30 August 2016 (17:42 - 17:51)
Organised by:
Congress Presentation Part of: Antithrombotics in daily clinical practice Thrombosis and coagulation ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Dietmar Trenk

University Heart Centre Freiburg-Bad Krozingen, Bad Krozingen (Germany)

9 More presentations in this session

Presentation thumbnail
Equal safety of rivaroxaban and vitamin K antagonists with regard to the risk of intracranial- and gastrointestinal bleeding in patients with venous thromboembolism - A Danish nationwide study
Ms C. Sindet-Pedersen (Hellerup, DK)
Abstract
Presentation thumbnail
Risk of venous thromboembolism recurrences in patients who continued versus discontinued rivaroxaban therapy after an initial six-month therapy
Doctor C. Crivera (Raritan, NJ, US)
Abstract Slides Video
Presentation thumbnail
Very low-dose recombinant factor VIIa for optimized treatment of cardiovascular patients at high risk of hemorrhage
Doctor A. Assmann (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Efficacy and bleeding risk of newer anticoagulants compared to conventional treatment in patients with chronic kidney disease- a meta analysis of randomized controlled trials
Assistant Professor K. Prudhvi (Tucson, US)
Abstract Slides Video
Presentation thumbnail
Management of acute venous thromboembolism in Europe - follow-up data at 1 month from the PREFER in VTE registry
Doctor A. Cohen (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Antithrombotics in daily clinical practice

The Event

Event poster

ESC Congress 2016

30 August 2016 17:42 CET
You may be interested in
thumbnail
Congress Session
Antithrombotic therapy for critically ill patients: focusing on anticoagulants
26 March 2023
thumbnail
Congress Presentation
Impact of heparin induced thrombocytopenia (HIT) in outcomes of patients admitted to the hospital with heart failure- a national perspective in United States
29 June 2021
thumbnail
Congress Presentation
Activated clotting time for anticoagulation management during left-atrial catheter ablation: an international survey of current strategies
12 April 2026
thumbnail
Congress Presentation
Anticoagulation management of heartware left ventricular assist device thrombosis: comparison of heparin and bivalirudin
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources